Breast Surgery Practice Questions

Q: The Van Nuys prognostic index is not based on which of the following parameters?

Estrogen receptor status. The **Van Nuys Prognostic Index (VNPI)** is a scoring system used specifically for **Ductal Carcinoma In Situ (DCIS)** to predict the risk of local recurrence and guide the decision between breast-conserving surgery alone, surgery with radiation, or mastectomy. ### **Explanation of the Correct Answer** **D. Estrogen receptor (ER) status:** While ER status is crucial for deciding hormonal therapy in invasive breast cancer, it is **not** a component of the Van Nuys Prognostic Index. The VNPI focuses on clinical and pathological features that predict local recurrence risk rather than molecular markers. ### **Explanation of Incorrect Options** The VNPI is based on four specific parameters, each scored from 1 to 3: * **A. Age:** Younger age (especially <40) is associated with a higher risk of recurrence. * **C. Size:** Larger tumors have a higher likelihood of residual disease. * **Tumor Grade/Pathology:** This includes the presence of **comedo-type necrosis** and nuclear grade. * **Margin Width:** The distance between the tumor and the surgical resection margin. **B. Microcalcification:** While not a direct scoring parameter, microcalcifications are the primary mammographic finding of DCIS. However, in the context of this question, it is often confused with "Pathological classification" or "Size." Since ER status is definitively excluded from the scoring system, it remains the most accurate answer. ### **Clinical Pearls for NEET-PG** * **VNPI Scoring:** Scores range from 4 to 12. * **4-6:** Low risk (Excision alone). * **7-9:** Intermediate risk (Excision + Radiation). * **10-12:** High risk (Mastectomy). * **Modified VNPI:** The original index (1996) had three parameters (Size, Margin, Grade); **Age** was added later to create the University of Southern California (USC)/Van Nuys Prognostic Index. * **DCIS Hallmark:** The most common presentation is **microcalcifications** on screening mammography.

Q: What is the most frequently used procedure for diagnosing palpable breast masses?

Fine needle aspiration. **Explanation:** The diagnosis of a palpable breast mass follows the **Triple Assessment** protocol: Clinical examination, Imaging (Mammography/Ultrasound), and Pathological diagnosis. **Why Fine Needle Aspiration (FNA) is the correct answer:** FNA is the **most frequently used** initial procedure for palpable breast masses because it is minimally invasive, cost-effective, and provides rapid results. It is highly accurate in distinguishing between cystic and solid lesions. In a clinical setting, if a cyst is suspected, FNA serves both a diagnostic and therapeutic purpose (aspiration leads to disappearance of the lump). **Analysis of Incorrect Options:** * **Core-cutting needle biopsy (CNB):** While CNB is the **Gold Standard** and the preferred method for non-palpable, suspicious lesions (as it preserves tissue architecture and allows for IHC markers like ER/PR/HER2), it is technically more demanding and expensive than FNA, making it the second most frequent choice. * **Excisional biopsy:** This involves removing the entire lump. It was historically common but is now reserved for cases where needle biopsies are inconclusive or for specific lesions like Fibroadenomas (if requested by the patient). * **Incisional biopsy:** This involves removing only a piece of a large mass. It is rarely used today, typically only for very large, inoperable locally advanced breast cancers where a core biopsy is insufficient. **Clinical Pearls for NEET-PG:** * **Triple Assessment:** If all three components (Clinical, Imaging, Cytology) are concordant, the diagnostic accuracy exceeds **99%**. * **FNA Limitation:** It cannot distinguish between **In-situ (DCIS)** and **Invasive carcinoma** because it only evaluates cytology, not tissue architecture. * **Gold Standard:** Core-cutting biopsy is the investigation of choice for definitive diagnosis before definitive surgery.

Q: Zuska disease is an eponym for what condition?

Squamous metaplasia of lactiferous ducts in the breast. **Explanation:** **Zuska’s Disease**, also known as **Squamous Metaplasia of Lactiferous Ducts (SMID)**, is a condition characterized by the triad of recurrent subareolar abscesses, draining fistulas, and nipple retraction. **Why Option A is correct:** The underlying pathophysiology involves the replacement of the normal double-layered cuboidal epithelium of the lactiferous ducts with **keratinizing squamous epithelium**. This leads to the accumulation of keratin debris, which plugs the ducts, causing proximal dilatation, stasis, and secondary bacterial infection. This eventually results in a periductal abscess that typically ruptures at the edge of the areola, forming a **periareolar fistula**. **Why other options are incorrect:** * **Option B:** Chronic inflammation of the bile ducts is typically associated with conditions like Primary Sclerosing Cholangitis (PSC), not Zuska’s disease. * **Option C:** Chronic renal transplant rejection involves graft fibrosis and vascular changes (obliterative arteriopathy), unrelated to this breast pathology. **High-Yield Clinical Pearls for NEET-PG:** * **Strongest Risk Factor:** **Smoking** is the most significant risk factor (found in >90% of patients). Smoking-induced toxins are thought to cause direct damage to the ductal epithelium. * **Clinical Presentation:** Recurrent periareolar abscesses that fail to resolve with simple incision and drainage (I&D). * **Management:** Simple I&D has a high recurrence rate. The definitive treatment is **Hadfield’s Procedure** (Total Duct Excision) or excision of the affected duct along with the fistula tract and the associated segment of the nipple-areolar complex. * **Differential Diagnosis:** Must be distinguished from idiopathic granulomatous mastitis and breast cancer (due to nipple retraction).

Q: A 40-year-old female presented to the OPD with a lesion in the breast. What is the most probable diagnosis?

Paget's disease of the nipple. ***Paget's disease of the nipple*** - Presents with **eczematous changes** of the nipple and areola, including scaling, crusting, and erythema that may resemble dermatitis. - Almost always associated with underlying **invasive ductal carcinoma** or **DCIS**, making it a significant clinical finding requiring immediate evaluation. *Ductal carcinoma in situ (DCIS)* - Typically presents as **microcalcifications** on mammography or as a palpable mass, not as nipple skin changes. - Does not cause the characteristic **eczematous nipple-areola complex** changes seen in this presentation. *Lobular carcinoma in situ (LCIS)* - Usually **asymptomatic** and discovered incidentally on breast biopsy, not presenting as a visible lesion. - Considered a **high-risk marker** rather than true malignancy and does not cause nipple skin changes. *Peau-d'orange* - Characterized by **skin dimpling** and **orange peel appearance** due to lymphatic obstruction in inflammatory breast cancer. - Affects the **breast skin surface** rather than specifically targeting the nipple-areola complex.

Q: What is the treatment of choice for a duct papilloma of the breast?

Microdochectomy. ### Explanation **Duct papilloma** is the most common cause of spontaneous, bloody nipple discharge from a single duct. It is a benign proliferative lesion arising from the epithelium of the lactiferous ducts. **Why Microdochectomy is the Correct Answer:** Microdochectomy is the surgical removal of a **single** offending duct. Since a solitary duct papilloma is usually localized to one duct, this procedure is both diagnostic and therapeutic. It involves identifying the discharging duct (often using a fine lacrimal probe or by injecting dye) and excising it through a periareolar incision. This approach is breast-conserving and preserves the function of the remaining ducts. **Why Other Options are Incorrect:** * **Simple Mastectomy:** This is an over-treatment for a benign condition. Mastectomy is reserved for malignant lesions (like DCIS or invasive cancer) or occasionally for prophylaxis in high-risk genetic cases. * **Local Wide Excision:** This involves removing a lump with a margin of healthy tissue. Since a papilloma is often non-palpable and located within the ductal system, a wide excision is less precise than a targeted microdochectomy. * **Chemotherapy:** This is used for systemic management of malignant breast cancer. It has no role in the management of benign lesions like duct papilloma. **Clinical Pearls for NEET-PG:** * **Triple Assessment:** Always perform clinical examination, imaging (USG/Mammography), and cytology/biopsy to rule out papillary carcinoma. * **Hadfield’s Procedure (Total Duct Excision):** This is the treatment of choice if there is discharge from **multiple ducts** or in older women who have completed childbearing. * **Age Factor:** Solitary papillomas usually occur in younger women (30-50 years), while multiple papillomas (which have a higher risk of malignancy) often occur in slightly younger age groups but involve the peripheral ducts.

Q: All of the following are true regarding gynecomastia except:

May be seen in Addison's disease. **Explanation:** Gynecomastia is the benign proliferation of glandular breast tissue in males, primarily driven by an imbalance between estrogen and androgen action. **1. Why Option A is the Correct Answer (The False Statement):** Gynecomastia is associated with **Thyrotoxicosis** (Hyperthyroidism) and **Liver Cirrhosis**, but it is **not** a feature of Addison’s disease (primary adrenal insufficiency). In fact, gynecomastia is more commonly associated with **Cushing’s Syndrome** (due to increased peripheral aromatization) or certain adrenal tumors that secrete estrogens. **2. Analysis of Other Options:** * **Option B (Usually unilateral in young males):** In pubertal boys (13–15 years), gynecomastia is very common and frequently presents as a **unilateral**, tender, discoid mass beneath the areola. While it can be bilateral, the initial presentation is often asymmetrical or unilateral. * **Option C (Acini are not involved):** This is a high-yield histopathological fact. Male breast tissue lacks the progesterone-driven development required for lobule (acinus) formation. Therefore, gynecomastia involves **ductal hyperplasia** and periductal stromal edema, but **no acini**. * **Option D (Bilaterality is due to endocrinopathy):** When gynecomastia is bilateral and persistent, it usually points to a systemic hormonal imbalance (e.g., Klinefelter syndrome, testicular tumors, or drug-induced causes) rather than a transient physiological shift. **NEET-PG High-Yield Pearls:** * **Most common cause:** Physiological (Puberty/Senescence). * **Drug-induced causes (Mnemonic: DISCO):** **D**igoxin, **I**soniazid, **S**pironolactone, **C**imetidine, **O**estrogens. * **Grading:** Uses the **Simon Scale** (Grade I to III). * **Treatment:** Reassurance for physiological cases; **Tamoxifen** (SERM) for painful/early medical cases; **Subcutaneous mastectomy** for persistent/cosmetic cases.

Question 1

What is the recommended treatment for a 35-year-old male patient presenting with specific symptoms (not detailed here)?

Accepted Answer

Mastectomy with nipple-areola preservation

Answer

Cystectomy

Answer

Intravenous antibiotics

Answer

Radical mastectomy

Question 2

The Van Nuys prognostic index is not based on which of the following parameters?

Accepted Answer

Estrogen receptor status

Answer

Age

Answer

Microcalcification

Answer

Size

Question 3

What is the most frequently used procedure for diagnosing palpable breast masses?

Accepted Answer

Fine needle aspiration

Answer

Core-cutting needle biopsy

Answer

Excisional biopsy

Answer

Incisional biopsy

Question 4

Zuska disease is an eponym for what condition?

Accepted Answer

Squamous metaplasia of lactiferous ducts in the breast

Answer

Chronic inflammation of bile ducts

Answer

Chronic renal transplant rejection

Answer

None of the above

Question 5

A 40-year-old female presented to the OPD with a lesion in the breast. What is the most probable diagnosis?

Accepted Answer

Paget's disease of the nipple

Answer

Ductal carcinoma in situ (DCIS)

Answer

Lobular carcinoma in situ (LCIS)

Answer

Peau-d'orange

Question 6

A 17-year-old female underwent Fine Needle Aspiration cytology (FNAC) for a lump in the breast which was non-tender, firm and mobile. Which of the following features would suggest a benign breast disease?

Accepted Answer

Tightly arranged ductal epithelial cells with dyscohesive bare nuclei

Answer

Dyscohesive ductal epithelial cells without cellular fragments

Answer

Stromal predominance with spindle cells

Answer

Polymorphism with single or arranged ductal epithelial cells

Question 7

Which of the following is not included in the carcinoma in-situ category?

Accepted Answer

Lobular carcinoma in situ (LCIS)

Answer

Ductal carcinoma in situ (DCIS)

Answer

Paget's disease of the nipple

Answer

None of the above

Question 8

What is the treatment of choice for a duct papilloma of the breast?

Accepted Answer

Microdochectomy

Answer

Simple mastectomy

Answer

Local wide excision

Answer

Chemotherapy

Question 9

All of the following are true regarding gynecomastia except:

Accepted Answer

May be seen in Addison's disease

Answer

Usually unilateral in young males

Answer

Acini are not involved

Answer

Bilaterality is due to endocrinopathy

Question 10

What is the first lymph node involved in breast cancer?

Accepted Answer

Contralateral axillary

Answer

Axillary

Answer

Internal mammary

Answer

Supraclavicular

Breast Surgery — MCQs

Breast Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?